Filing Details
- Accession Number:
- 0001209191-21-051011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-11 21:37:10
- Reporting Period:
- 2021-08-09
- Accepted Time:
- 2021-08-11 21:37:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1496323 | Igm Biosciences Inc. | IGMS | Pharmaceutical Preparations (2834) | 770349194 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1578771 | Julie Hambleton | C/O Igm Biosciences, Inc. 325 E Middlefield Road Mountain View CA 94043 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-08-09 | 1,000 | $80.00 | 2,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
Billionaire Hedge Funds
